WEBSITE BSE:544440 NSE: CRYOGENIC Inc. Year: 1997 Industry: Engineering - Industrial Equipments My Bucket: Add Stock
Last updated: 11:27
No Notes Added Yet
Cryogenic OGS Limited, headquartered in Vadodara, Gujarat, is an engineering‑manufacturing firm that builds precision measurement and filtration equipment for the oil, gas, chemical and other fluid‑handling industries. Its products include basket strainers, air‑eliminators, prover tanks, additive‑dosing skids, and loading‑/metering‑skids for liquid and gas, designed and fabricated in its ~8,300 sq meter facility. Originally incorporated in 1997 (as Mangukia Steel Private Limited) it was renamed Cryogenic OGS in 2023, and conve...Read More
Cryogenic OGS Limited, headquartered in Vadodara, Gujarat, is an engineering‑manufacturing firm that builds precision measurement and filtration equipment for the oil, gas, chemical and other fluid‑handling industries. Its products include basket strainers, air‑eliminators, prover tanks, additive‑dosing skids, and loading‑/metering‑skids for liquid and gas, designed and fabricated in its ~8,300 sq meter facility. Originally incorporated in 1997 (as Mangukia Steel Private Limited) it was renamed Cryogenic OGS in 2023, and converted to a public limited company. In July 2025 the company launched an IPO on the BSE SME platform — issuing fresh shares (≈ 37.8 lakh) at a price band of ₹44‑₹47 per share. In FY 2025, Cryogenic OGS posted revenue of about ₹33.79 crore and a net profit of around ₹6.12 crore, marking growth compared with the previous year. The company claims a track record of supplying to major oil, gas, and terminal automation clients, with ambitions to serve emerging clean‑energy sectors (e.g. hydrogen, LNG) via its advanced filtration and metering solutions. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹276 Cr.
Stock P/E 45.1
P/B 5.9
Current Price ₹193.3
Book Value ₹ 32.7
Face Value 10
52W High ₹268
Dividend Yield 0%
52W Low ₹ 89.3
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|
| Net Sales | 23 | 22 | 24 | 33 | |
| Other Income | 1 | 1 | 1 | 1 | |
| Total Income | 24 | 23 | 26 | 34 | |
| Total Expenditure | 19 | 16 | 18 | 25 | |
| Operating Profit | 5 | 6 | 8 | 9 | |
| Interest | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 1 | 1 | 1 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 4 | 5 | 7 | 8 | |
| Provision for Tax | 1 | 1 | 2 | 2 | |
| Profit After Tax | 3 | 4 | 5 | 6 | |
| Adjustments | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 3 | 4 | 5 | 6 | |
| Adjusted Earnings Per Share | 3.1 | 3.9 | 5.1 | 5.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 38% | 13% | 0% | 0% |
| Operating Profit CAGR | 13% | 22% | 0% | 0% |
| PAT CAGR | 20% | 26% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 24% | 25% | 25% | 25% |
| ROCE Average | 32% | 34% | 33% | 33% |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Shareholder's Funds | 13 | 18 | 23 | 29 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | -0 | 0 |
| Total Current Liabilities | 9 | 6 | 5 | 5 |
| Total Liabilities | 22 | 24 | 28 | 34 |
| Fixed Assets | 8 | 7 | 7 | 7 |
| Other Non-Current Assets | 1 | 1 | 2 | 3 |
| Total Current Assets | 14 | 15 | 19 | 24 |
| Total Assets | 22 | 24 | 28 | 34 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 8 | 8 | 8 | 10 |
| Cash Flow from Operating Activities | 2 | 2 | 2 | 2 |
| Cash Flow from Investing Activities | -1 | -0 | -1 | -1 |
| Cash Flow from Financing Activities | -1 | -2 | -0 | -0 |
| Net Cash Inflow / Outflow | 1 | 0 | 0 | 1 |
| Closing Cash & Cash Equivalent | 8 | 8 | 8 | 10 |
| # | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 3.13 | 3.88 | 5.09 | 5.83 |
| CEPS(Rs) | 3.59 | 4.53 | 5.63 | 6.33 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 12.8 | 16.68 | 21.77 | 27.61 |
| Core EBITDA Margin(%) | 18.63 | 25.65 | 26.33 | 24.2 |
| EBIT Margin(%) | 19.42 | 25.7 | 29.85 | 25.31 |
| Pre Tax Margin(%) | 18.97 | 24.87 | 29.36 | 25.13 |
| PAT Margin (%) | 14.07 | 18.51 | 22.04 | 18.61 |
| Cash Profit Margin (%) | 16.15 | 21.59 | 24.37 | 20.19 |
| ROA(%) | 14.65 | 17.59 | 20.55 | 19.82 |
| ROE(%) | 24.41 | 26.33 | 26.47 | 23.62 |
| ROCE(%) | 30.19 | 34.8 | 35.86 | 32.12 |
| Receivable days | 41.23 | 64.43 | 78.87 | 66.37 |
| Inventory Days | 38.08 | 35.99 | 43.93 | 53.88 |
| Payable days | 160.65 | 181.36 | 130.39 | 70 |
| PER(x) | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | -0.25 | -0.35 | -0.37 | -0.02 |
| EV/Core EBITDA(x) | -1.18 | -1.2 | -1.16 | -0.06 |
| Net Sales Growth(%) | 0 | -5.61 | 10.14 | 35.67 |
| EBIT Growth(%) | 0 | 24.91 | 27.94 | 15.03 |
| PAT Growth(%) | 0 | 24.23 | 31.12 | 14.55 |
| EPS Growth(%) | 0 | 24.23 | 31.12 | 14.55 |
| Debt/Equity(x) | 0.12 | 0 | 0 | 0 |
| Current Ratio(x) | 1.54 | 2.43 | 3.62 | 5.26 |
| Quick Ratio(x) | 1.26 | 2.13 | 2.87 | 4 |
| Interest Cover(x) | 43.81 | 31.3 | 60.43 | 139.26 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
| # | Jun 2025 | Jul 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Promoter | 73.53 | 73.53 | 73.53 | 74.29 |
| FII | 3.34 | 3.34 | 1.51 | 0 |
| DII | 8.53 | 8.53 | 3.51 | 1.65 |
| Public | 14.6 | 14.6 | 21.45 | 24.06 |
| Others | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 |
| # | Jun 2025 | Jul 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Promoter | 1.05 | 1.05 | 1.05 | 1.06 |
| FII | 0.05 | 0.05 | 0.02 | 0 |
| DII | 0.12 | 0.12 | 0.05 | 0.02 |
| Public | 0.21 | 0.21 | 0.31 | 0.34 |
| Others | 0 | 0 | 0 | 0 |
| Total | 1.43 | 1.43 | 1.43 | 1.43 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
